Abstract
The antipruritic effect of DA-5018, a capsaicin derivative, was examined in mice. Male ICR mice were topically pretreated with Zostrix-HP (0.075% capsaicin cream), 0.1%, 0.3% DA-5018 cream or cream base (control) twice daily for 4 days. One hour after the last application, itch was induced either by compound 48/80 (50μg, s.c.) or leukotriene B4 (0.03 nmol, i.d.) injection into the rostral back of the animals, and the number of scratches made by the animals at the injection site was counted for 60 min post-injection. DA-5018 cream (both 0.1 and 0.3%) significantly inhibited compound 48/80-induced scratching when compared with the cream base control (p<0.01), while Zostrix-HP showed minimal inhibition of the scratching behavior. In leukotriene B4-induced itch model, Zostrix-HP and 0.3% DA-5018 cream significantly inhibited the scratching during the first 10-min period (p<0.01). The results suggest that DA-5018 cream can be used as an antipruritic agent and warrant clinical evaluation.
Similar content being viewed by others
References Cited
Andoh, T. and Kuraishi, Y., Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice.Eur. J. Pharmacol., 353, 93–96 (1998).
Andoh, T., Nagasawa, T. and Kuraishi, Y., Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse.Mol. Brain Res., 35, 329–332 (1996).
Bae, E. J., Kim, S. H., Son, M. H., Kim, H. K., Shin, M. S., Kim, H. J. and Kim, W. B., Analgesic effects of DA-5018, a new capsaicin derivative, in hyperalgesia of experimental diabetic neuropathy.J. Kor. Diabetes Assoc., 21, 69–79 (1997).
Basha, K. M. and Whitehouse, F. W., Capsaicin: a therapeutic option for painful diabetic neuropathy.Henry Ford Hosp. Med. J., 39, 138–140 (1991).
Bernstein, J. E., Parish, L. C., Rapaport, M., Rosenbaum, M. M. and Roenigk, H. H. Jr., Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris.J. Am. Acad. Dermatol., 15, 504–507 (1986).
Bernstein, J. E., Swift, R. M., Soltani, K. and Lorincz, A. L., Antipruritic effect of an opiate antagonist, naloxone hydrochloride.J. Invest. Dermatol., 78, 82–83 (1982).
Bjerring, P. and Arendt-Nielsen, L., Inhibition of histamine skin flare reaction following repeated topical applications of capsaicin.Allergy, 45, 121–125 (1990).
Devillier, P., Drapeau, G., Renoux, M. and Regoli, D., Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides.Eur. J. Pharmacol., 168, 53–69 (1989).
Dunnett, C. W., A multiple comparison procedure for comparing several treatments with a control.J. Am. Stat. Assoc., 50, 1096–1121 (1955).
Ebertz, J. M., Hirshman, C. A., Kettelkamp, N. S., Uno, H. and Hanifin, J. M., Substance P-induced histamine release in human cutaneous mast cells.J. Invest. Dermatol., 88, 682–685 (1987).
Ellis, C. N., Berberian, B., Sulica, V. I., Dodd, W. A., Jarratt, M. T., Katz, H. I., Prawer, S., Krueger, G., Rex, I. H. Jr. and Wolf, J. E., A double-blind evaluation of topical capsaicin in pruritic psoriasis.J. Am. Acad. Dermatol., 9, 438–442 (1993).
Farber, E. M., Nickoloff, B. J., Recht, B. and Fraki, J. E., Stress, symmetry, and psoriasis: possible role of neuropeptides.J. Am. Acad. Dermatol., 14, 305–311 (1986).
Goodless, D. R. and Eaglstein, W. H., Branchioradial pruritus: treatment with topical capsaicin.J. Acad. Dermatol., 29, 783–784 (1993).
Hagermark, O., Peripheral and central mediators of itch.Skin Pharmacol., 5, 1–8 (1992).
Hagermark, O., Hokfelt, T. and Pernow, B., Flare and itch induced by substance P in human skin.J. Invest. Dermatol., 71, 233–235 (1978).
Handwerker, H. O., Pain and allodynia, itch and alloknesis: an alternative hypothesis.APS. J., 1, 135–139 (1992).
Kim, H. K., Bae, E. J., Shin, M. S., Son, M. H., Kim, S. H., Kim, W. B., Yang, J. and Kong, J. Y., Analgesic effects of DA-5018, a new capsaicin derivative after subcutaneous injection and topical application.J. Appl. Pharmacol., 5, 117–124 (1997).
Kim, O. J., Kim, D. H., Kang, K. K., Baik, N. G., Kim, W. B. and Yang, J., Primary skin and eye irritation test of 0.3% DA-5018 cream, a new non-narcotic analgesic.J. Appl. Pharmacol., 4, 364–372 (1996).
Kuraishi, Y., Nagasawa, T., Hayashi, K. and Satoh, M., Scratching behavior induced by pruritogenic but not algesiogenic agents in mice.Eur. J. Pharmacol., 275, 229–233 (1995).
Lotti, T., Teofoli, P. and Tsampau, D., Treatment of aquagenic pruritus with topical capsaicin cream.J. Am. Acad. Dermatol., 30, 232–235 (1994).
Martin, H. A., Basbaum, A. I., Goetzl, E. J. and Levine, J. D., Leukotriene B4 decreases the mechanical and thermal thresolds of C-fiber nociceptors in the hairy skin of the rat.J. Neurophysiol., 60, 438–445 (1988).
Peikert, A., Hentrich, M. and Ochs, G., Topical 0.025% capsaicin in chronic post-herpetic neuralgia: efficacy, predictors of response and long-term course.J. Neurol., 238, 452–456 (1991).
Rojavin, M. A., Cowan, A., Radzievsky, A. A. and Ziskin, M. C., Antipruritic effect of millimeter waves in mice: evidence for opioid involvement.Life Sci., 63, PL251-PL257 (1998).
Scheffler, N. M., Sheitel, P. L. and Lipton, M. N., Treatment of painful diabetic neuropathy with capsaicin 0.075%.J. Am. Podiatr. Med. Assoc., 81, 288–293 (1991).
Schmelz, M., Schmidt, R., Bickel, A., Handwerker, H. O. and Torebjork, H. E., Specific C-receptors for itch in human skin.J. Neurosci., 17, 8003–8008 (1997).
Son, M. H., Bae, E. J., Kim, H. K., Shin, M. S., Kim, S. H., Kim, W. B., Yang, J. and Park, N. S., Analgesic effects of DA-5018, a new capsaicin derivative, against experimental acute pain.J. Appl. Pharmacol., 5, 67–73 (1997).
von Frey, M., Zur physiologie der juckempfindung.Arch. Neerland Physiol., 7, 142–145 (1922).
Wahlgren, C-F., Hagermark, O. and Bergstrom, R., Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis.Acta. Derm. Venereol., 71, 488–494 (1990).
Wallengren, J., Treatment of notalgia paresthetica with topical capsaicin.J. Am. Acad. Dermatol., 24, 286–288 (1991).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, D.H., Ahn, B.O., Kim, S.H. et al. Antipruritic effect of DA-5018, a capsaicin derivative, in mice. Arch Pharm Res 22, 549–553 (1999). https://doi.org/10.1007/BF02975324
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02975324